| Product Code: ETC6857318 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Croatia Oncology NGS Market Overview |
3.1 Croatia Country Macro Economic Indicators |
3.2 Croatia Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Croatia Oncology NGS Market - Industry Life Cycle |
3.4 Croatia Oncology NGS Market - Porter's Five Forces |
3.5 Croatia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Croatia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Croatia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Croatia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Croatia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Croatia Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of cancer in Croatia |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology |
4.2.3 Rising demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology |
4.3.2 Limited reimbursement policies for NGS-based tests in Croatia |
4.3.3 Lack of skilled professionals in oncology NGS testing |
5 Croatia Oncology NGS Market Trends |
6 Croatia Oncology NGS Market, By Types |
6.1 Croatia Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Croatia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Croatia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Croatia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Croatia Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Croatia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Croatia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Croatia Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Croatia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Croatia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Croatia Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Croatia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Croatia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Croatia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Croatia Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Croatia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Croatia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Croatia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Croatia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Croatia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Croatia Oncology NGS Market Import-Export Trade Statistics |
7.1 Croatia Oncology NGS Market Export to Major Countries |
7.2 Croatia Oncology NGS Market Imports from Major Countries |
8 Croatia Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in oncology |
8.2 Number of clinical trials utilizing NGS technology in Croatia |
8.3 Rate of adoption of NGS-based tests by oncologists in Croatia |
9 Croatia Oncology NGS Market - Opportunity Assessment |
9.1 Croatia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Croatia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Croatia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Croatia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Croatia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Croatia Oncology NGS Market - Competitive Landscape |
10.1 Croatia Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Croatia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here